- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/77 - Hydrazine radicals
Patent holdings for IPC class C07D 213/77
Total number of patents in this class: 61
10-year publication summary
|
6
|
4
|
3
|
5
|
2
|
5
|
6
|
0
|
4
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| HMI Medical Innovations, LLC | 21 |
8 |
| Clariant International Ltd. | 924 |
4 |
| Kyoto University | 2770 |
4 |
| Daito Chemix Corporation | 12 |
3 |
| FMC Corporation | 843 |
3 |
| Corteva Agriscience LLC | 2621 |
3 |
| BASF SE | 20488 |
2 |
| Bayer Cropscience AG | 2096 |
2 |
| Fred Hutchinson Cancer Research Center | 360 |
2 |
| The University of Melbourne | 525 |
2 |
| FMC Agro Singapore Pte. Ltd. | 40 |
2 |
| PI Industries Ltd | 156 |
2 |
| Bristol-myers Squibb Company | 4845 |
1 |
| Bayer AG | 3217 |
1 |
| The Trustees of the University of Pennsylvania | 4268 |
1 |
| Henkel AG & Co. KGaA | 10328 |
1 |
| University of Florida Research Foundation, Inc. | 3964 |
1 |
| Alkermes, Inc. | 131 |
1 |
| Archroma IP GmbH | 454 |
1 |
| Clariant Finance (BVI) Limited | 398 |
1 |
| Other owners | 16 |